Abnormal Uterine Bleeding Is Associated with Increased BMP7 Expression in Human Endometrium

Elliott G. Richards, Sherif A. El-Nashar, J. Kenneth Schoolmeester, Gary Keeney, Andrea Mariani, Matthew R. Hopkins, Sean Christopher Dowdy, Gaurang S. Daftary, Abimbola O. Famuyide

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Abnormal uterine bleeding (AUB), a common health concern of women, is a heterogeneous clinical entity that is traditionally categorized into organic and nonorganic causes. Despite varied pharmacologic treatments, few offer sustained efficacy, as most are empiric, unfocused, and do not directly address underlying dysregulated molecular mechanisms. Characterization of such molecular derangements affords the opportunity to develop and use novel, more successful treatments for AUB. Given its implication in other organ systems, we hypothesized that bone morphogenetic protein (BMP) expression is altered in patients with AUB and hence comprehensively investigated dysregulation of BMP signaling pathways by systematically screening 489 samples from 365 patients for differences in the expression of BMP2, 4, 6, and 7 ligands, BMPR1A and B receptors, and downstream SMAD4, 6, and 7 proteins. Expression analysis was correlated clinically with data abstracted from medical records, including bleeding history, age at procedure, ethnicity, body mass index, hormone treatment, and histological diagnosis of fibroids, polyps, adenomyosis, hyperplasia, and cancer. Expression of BMP7 ligand was significantly increased in patients with AUB (H-score: 18.0 vs 26.7; P <.0001). Patients reporting heavy menstrual bleeding (menorrhagia) as their specific AUB pattern demonstrated significantly higher BMP7 expression. Significantly, no differences in the expression of any other BMP ligands, receptors, or SMAD proteins were observed in this large patient cohort. However, expression of BMPR1A, BMPR1B, and SMAD4 was significantly decreased in cancer compared to benign samples. Our study demonstrates that BMP7 is a promising target for future investigation and pharmacologic treatment of AUB.

Original languageEnglish (US)
Pages (from-to)671-681
Number of pages11
JournalReproductive Sciences
Volume24
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Uterine Hemorrhage
Endometrium
Bone Morphogenetic Proteins
Ligands
Bone Morphogenetic Protein Receptors
Adenomyosis
Hemorrhage
Menorrhagia
Leiomyoma
Women's Health
Therapeutics
Polyps
Hyperplasia
Medical Records
Neoplasms
Proteins
Body Mass Index
Hormones

Keywords

  • abnormal uterine bleeding
  • BMP
  • menstrual cycle
  • SMAD

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Abnormal Uterine Bleeding Is Associated with Increased BMP7 Expression in Human Endometrium. / Richards, Elliott G.; El-Nashar, Sherif A.; Schoolmeester, J. Kenneth; Keeney, Gary; Mariani, Andrea; Hopkins, Matthew R.; Dowdy, Sean Christopher; Daftary, Gaurang S.; Famuyide, Abimbola O.

In: Reproductive Sciences, Vol. 24, No. 5, 01.05.2017, p. 671-681.

Research output: Contribution to journalArticle

Richards, Elliott G. ; El-Nashar, Sherif A. ; Schoolmeester, J. Kenneth ; Keeney, Gary ; Mariani, Andrea ; Hopkins, Matthew R. ; Dowdy, Sean Christopher ; Daftary, Gaurang S. ; Famuyide, Abimbola O. / Abnormal Uterine Bleeding Is Associated with Increased BMP7 Expression in Human Endometrium. In: Reproductive Sciences. 2017 ; Vol. 24, No. 5. pp. 671-681.
@article{a23685cd7eb44f689a51f68a171f75b4,
title = "Abnormal Uterine Bleeding Is Associated with Increased BMP7 Expression in Human Endometrium",
abstract = "Abnormal uterine bleeding (AUB), a common health concern of women, is a heterogeneous clinical entity that is traditionally categorized into organic and nonorganic causes. Despite varied pharmacologic treatments, few offer sustained efficacy, as most are empiric, unfocused, and do not directly address underlying dysregulated molecular mechanisms. Characterization of such molecular derangements affords the opportunity to develop and use novel, more successful treatments for AUB. Given its implication in other organ systems, we hypothesized that bone morphogenetic protein (BMP) expression is altered in patients with AUB and hence comprehensively investigated dysregulation of BMP signaling pathways by systematically screening 489 samples from 365 patients for differences in the expression of BMP2, 4, 6, and 7 ligands, BMPR1A and B receptors, and downstream SMAD4, 6, and 7 proteins. Expression analysis was correlated clinically with data abstracted from medical records, including bleeding history, age at procedure, ethnicity, body mass index, hormone treatment, and histological diagnosis of fibroids, polyps, adenomyosis, hyperplasia, and cancer. Expression of BMP7 ligand was significantly increased in patients with AUB (H-score: 18.0 vs 26.7; P <.0001). Patients reporting heavy menstrual bleeding (menorrhagia) as their specific AUB pattern demonstrated significantly higher BMP7 expression. Significantly, no differences in the expression of any other BMP ligands, receptors, or SMAD proteins were observed in this large patient cohort. However, expression of BMPR1A, BMPR1B, and SMAD4 was significantly decreased in cancer compared to benign samples. Our study demonstrates that BMP7 is a promising target for future investigation and pharmacologic treatment of AUB.",
keywords = "abnormal uterine bleeding, BMP, menstrual cycle, SMAD",
author = "Richards, {Elliott G.} and El-Nashar, {Sherif A.} and Schoolmeester, {J. Kenneth} and Gary Keeney and Andrea Mariani and Hopkins, {Matthew R.} and Dowdy, {Sean Christopher} and Daftary, {Gaurang S.} and Famuyide, {Abimbola O.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1177/1933719116671218",
language = "English (US)",
volume = "24",
pages = "671--681",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Abnormal Uterine Bleeding Is Associated with Increased BMP7 Expression in Human Endometrium

AU - Richards, Elliott G.

AU - El-Nashar, Sherif A.

AU - Schoolmeester, J. Kenneth

AU - Keeney, Gary

AU - Mariani, Andrea

AU - Hopkins, Matthew R.

AU - Dowdy, Sean Christopher

AU - Daftary, Gaurang S.

AU - Famuyide, Abimbola O.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Abnormal uterine bleeding (AUB), a common health concern of women, is a heterogeneous clinical entity that is traditionally categorized into organic and nonorganic causes. Despite varied pharmacologic treatments, few offer sustained efficacy, as most are empiric, unfocused, and do not directly address underlying dysregulated molecular mechanisms. Characterization of such molecular derangements affords the opportunity to develop and use novel, more successful treatments for AUB. Given its implication in other organ systems, we hypothesized that bone morphogenetic protein (BMP) expression is altered in patients with AUB and hence comprehensively investigated dysregulation of BMP signaling pathways by systematically screening 489 samples from 365 patients for differences in the expression of BMP2, 4, 6, and 7 ligands, BMPR1A and B receptors, and downstream SMAD4, 6, and 7 proteins. Expression analysis was correlated clinically with data abstracted from medical records, including bleeding history, age at procedure, ethnicity, body mass index, hormone treatment, and histological diagnosis of fibroids, polyps, adenomyosis, hyperplasia, and cancer. Expression of BMP7 ligand was significantly increased in patients with AUB (H-score: 18.0 vs 26.7; P <.0001). Patients reporting heavy menstrual bleeding (menorrhagia) as their specific AUB pattern demonstrated significantly higher BMP7 expression. Significantly, no differences in the expression of any other BMP ligands, receptors, or SMAD proteins were observed in this large patient cohort. However, expression of BMPR1A, BMPR1B, and SMAD4 was significantly decreased in cancer compared to benign samples. Our study demonstrates that BMP7 is a promising target for future investigation and pharmacologic treatment of AUB.

AB - Abnormal uterine bleeding (AUB), a common health concern of women, is a heterogeneous clinical entity that is traditionally categorized into organic and nonorganic causes. Despite varied pharmacologic treatments, few offer sustained efficacy, as most are empiric, unfocused, and do not directly address underlying dysregulated molecular mechanisms. Characterization of such molecular derangements affords the opportunity to develop and use novel, more successful treatments for AUB. Given its implication in other organ systems, we hypothesized that bone morphogenetic protein (BMP) expression is altered in patients with AUB and hence comprehensively investigated dysregulation of BMP signaling pathways by systematically screening 489 samples from 365 patients for differences in the expression of BMP2, 4, 6, and 7 ligands, BMPR1A and B receptors, and downstream SMAD4, 6, and 7 proteins. Expression analysis was correlated clinically with data abstracted from medical records, including bleeding history, age at procedure, ethnicity, body mass index, hormone treatment, and histological diagnosis of fibroids, polyps, adenomyosis, hyperplasia, and cancer. Expression of BMP7 ligand was significantly increased in patients with AUB (H-score: 18.0 vs 26.7; P <.0001). Patients reporting heavy menstrual bleeding (menorrhagia) as their specific AUB pattern demonstrated significantly higher BMP7 expression. Significantly, no differences in the expression of any other BMP ligands, receptors, or SMAD proteins were observed in this large patient cohort. However, expression of BMPR1A, BMPR1B, and SMAD4 was significantly decreased in cancer compared to benign samples. Our study demonstrates that BMP7 is a promising target for future investigation and pharmacologic treatment of AUB.

KW - abnormal uterine bleeding

KW - BMP

KW - menstrual cycle

KW - SMAD

UR - http://www.scopus.com/inward/record.url?scp=85018222014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018222014&partnerID=8YFLogxK

U2 - 10.1177/1933719116671218

DO - 10.1177/1933719116671218

M3 - Article

VL - 24

SP - 671

EP - 681

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 5

ER -